# Expert Opinion on Emerging Drugs

**Type:** Journals  
**Canonical URL:** https://scholariq.org/journals/expert-opinion-on-emerging-drugs/

## Facts

| Field | Value |
| --- | --- |
| Open Access | false |
| ISSN-L | 1472-8214 |
| ISSNs | 1472-8214,1744-7623 |
| OpenAlex ID | https://openalex.org/S66445379 |
| Publisher | Taylor & Francis |

## Journal papers

- [Anti-amyloid-β protein agents for the treatment of Alzheimer’s disease: an update on emerging drugs](https://scholariq.org/papers/anti-amyloid-protein-agents-for-the-treatment-of-alzheimer-s-disease-an-update/)
- [Promising therapies for treatment of nonalcoholic steatohepatitis](https://scholariq.org/papers/promising-therapies-for-treatment-of-nonalcoholic-steatohepatitis/)
- [Emerging drugs for the treatment of L-DOPA-induced dyskinesia: an update](https://scholariq.org/papers/emerging-drugs-for-the-treatment-of-l-dopa-induced-dyskinesia-an-update/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.